Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to toxicity in human cells.
Mechanisms of Ergosterol Targeting
Amphotericin B interacts with ergosterol through three complementary models:
In the classic pore-formation model, amphotericin B-ergosterol complexes insert into the lipid bilayer, forming oligomeric transmembrane channels. These pores allow the uncontrolled leakage of intracellular ions, particularly potassium, disrupting ionic gradients and leading to cell death.
In the surface-aligned model, amphotericin B binds ergosterol while remaining parallel to the membrane. This alignment causes clustering of ergosterol at the membrane surface, disrupting lipid organization and compromising membrane integrity—without forming pores.
In the sponge model, amphotericin B aggregates sequester ergosterol into extracellular complexes. Rather than embedding in the membrane, these aggregates extract ergosterol, depleting it from the bilayer and impairing essential membrane functions.
Reactive Oxygen Species and Oxidative Stress
Beyond its membrane-disrupting actions, amphotericin B also triggers the production of reactive oxygen species (ROS), including superoxide anions, hydrogen peroxide, and hydroxyl radicals. These ROS cause oxidative damage to cellular components such as lipids, proteins, and nucleic acids. This oxidative stress operates independently of ergosterol binding, adding an additional mechanism to the drug’s fungicidal effects.
Antifungal agents target pathogenic fungi to prevent infections from spreading. For example, amphotericin B is one such agent that targets the fungal cell membrane.
Amphotericin B is an amphipathic molecule, containing both hydrophobic and hydrophilic regions.
The mycosamine and carboxylic acid groups in the hydrophilic region bind to ergosterol, a sterol predominant in the fungal plasma membrane. This binding stabilizes the molecule’s insertion into the lipid bilayer.
Once inserted, multiple amphotericin molecules align themselves with the surrounding lipid chains and assemble into pore-like channels.
These channels allow the uncontrolled leakage of ions, especially potassium, which causes an osmotic imbalance and leads to fungal cell death.
In another mechanism, amphotericin B molecules align parallel to the lipid bilayer.
This orientation sequesters ergosterol toward the membrane surface, disrupting membrane structural integrity.
繁體中文
